Rolling record / ARQ 63 Concerning · ▲ +2 7-day 3595 events in window / as of 02 Oct 2026
ARQAI Risk Quotient
medicine 45.4 Mixed

AbbVie Partners with Valkai for AI in Clinical Development

This partnership aims to leverage AI to improve efficiency and innovation in drug development, potentially advancing medical research.

This partnership aims to leverage AI to improve efficiency and innovation in drug development, potentially advancing medical research.

Auto-scored: Business collaboration with no indicated risks or mitigations for AI safety.